| 33 |
7.22E-06 |
(KEGG) 05200: Pathways in cancer |
| 22 |
3.43E-06 |
(KEGG) 03013: RNA transport |
| 21 |
1.01E-05 |
(KEGG) 04141: Protein processing in endoplasmic reticulum |
| 20 |
1.04E-02 |
(KEGG) 04010: MAPK signaling pathway |
| 20 |
7.57E-06 |
(KEGG) 04120: Ubiquitin mediated proteolysis |
| 20 |
2.30E-06 |
(KEGG) 04110: Cell cycle |
| 18 |
3.57E-04 |
(KEGG) 00230: Purine metabolism |
| 17 |
5.42E-04 |
(KEGG) 04310: Wnt signaling pathway |
| 16 |
1.40E-02 |
(KEGG) 04510: Focal adhesion |
| 16 |
1.03E-05 |
(KEGG) 00240: Pyrimidine metabolism |
| 15 |
1.17E-03 |
(KEGG) 05162: Measles |
| 14 |
2.82E-02 |
(KEGG) 05016: Huntington's disease |
| 14 |
4.34E-03 |
(KEGG) 04910: Insulin signaling pathway |
| 14 |
2.21E-03 |
(KEGG) 04722: Neurotrophin signaling pathway |
| 14 |
4.73E-05 |
(KEGG) 05222: Small cell lung cancer |
| 14 |
1.03E-05 |
(KEGG) 03008: Ribosome biogenesis in eukaryotes |
| 14 |
1.03E-05 |
(KEGG) 05220: Chronic myeloid leukemia |
| 13 |
4.22E-03 |
(KEGG) 03040: Spliceosome |
| 12 |
1.79E-02 |
(KEGG) 05160: Hepatitis C |
| 12 |
1.10E-03 |
(KEGG) 05215: Prostate cancer |
| 11 |
2.57E-02 |
(KEGG) 05145: Toxoplasmosis |
| 10 |
2.67E-02 |
(KEGG) 04660: T cell receptor signaling pathway |
| 10 |
8.29E-03 |
(KEGG) 04210: Apoptosis |
| 10 |
5.60E-03 |
(KEGG) 00564: Glycerophospholipid metabolism |
| 10 |
5.60E-03 |
(KEGG) 03015: mRNA surveillance pathway |
| 10 |
1.72E-04 |
(KEGG) 00510: N-Glycan biosynthesis |
| 9 |
2.15E-02 |
(KEGG) 04012: ErbB signaling pathway |
| 9 |
7.54E-03 |
(KEGG) 05212: Pancreatic cancer |
| 9 |
7.54E-03 |
(KEGG) 05211: Renal cell carcinoma |
| 9 |
5.90E-03 |
(KEGG) 04115: p53 signaling pathway |
| 9 |
5.90E-03 |
(KEGG) 04920: Adipocytokine signaling pathway |
| 9 |
5.40E-04 |
(KEGG) 04330: Notch signaling pathway |
| 8 |
2.68E-02 |
(KEGG) 04662: B cell receptor signaling pathway |
| 8 |
1.19E-02 |
(KEGG) 05214: Glioma |
| 8 |
1.01E-02 |
(KEGG) 04623: Cytosolic DNA-sensing pathway |
| 8 |
1.03E-04 |
(KEGG) 03020: RNA polymerase |
| 7 |
1.47E-02 |
(KEGG) 04150: mTOR signaling pathway |
| 7 |
5.77E-03 |
(KEGG) 03420: Nucleotide excision repair |
| 7 |
5.68E-03 |
(KEGG) 00970: Aminoacyl-tRNA biosynthesis |
| 6 |
4.91E-02 |
(KEGG) 05223: Non-small cell lung cancer |
| 6 |
2.93E-02 |
(KEGG) 00561: Glycerolipid metabolism |
| 6 |
1.95E-02 |
(KEGG) 05219: Bladder cancer |
| 6 |
1.63E-02 |
(KEGG) 03050: Proteasome |
| 6 |
9.83E-03 |
(KEGG) 04130: SNARE interactions in vesicular transport |
| 6 |
9.83E-03 |
(KEGG) 03030: DNA replication |
| 6 |
8.16E-03 |
(KEGG) 03410: Base excision repair |
| 5 |
1.27E-02 |
(KEGG) 00534: Glycosaminoglycan biosynthesis - heparan sulfate |
| 5 |
1.12E-02 |
(KEGG) 00563: Glycosylphosphatidylinositol(GPI)-anchor biosynthesis |
| 4 |
3.60E-02 |
(KEGG) 04320: Dorso-ventral axis formation |
| 4 |
3.12E-02 |
(KEGG) 00532: Glycosaminoglycan biosynthesis - chondroitin sulfate |
| 4 |
1.83E-02 |
(KEGG) 00670: One carbon pool by folate |
| 3 |
2.79E-02 |
(KEGG) 00740: Riboflavin metabolism |
